SCHEMBL7040762

SCHEMBL7040762

NCc1ccc(C(N)C(N)=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.43
ABAT P80404 1/20 0.43
TPSAB1 Q15661 3/20 0.42
HDAC3 O15379 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
NCOR2 Q9Y618 1/20 0.42
LOXL2 Q9Y4K0 4/20 0.42
F10 P00742 1/20 0.42
HRH3 Q9Y5N1 1/20 0.41
F2 P00734 1/20 0.40
NOS3 P29474 2/20 0.39
NOS1 P29475 2/20 0.39
NOS2 P35228 2/20 0.39
KDM4E B2RXH2 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ANPEP P15144 1/20 0.39
ERAP2 Q6P179 1/20 0.39
PLG P00747 1/20 0.38
KLK1 P06870 1/20 0.38
KLK6 Q92876 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8495584 0.83 HSD17B10 (0.48) ABATTPSAB1HDAC3HDAC6NCOR2
SCHEMBL8139642 0.83 EPHX1 (0.43) EPHX1F2NOS3NOS1PLG
SCHEMBL8279092 0.83 KDM4E (0.47) EPHX1ABATTPSAB1HDAC3HDAC6
SCHEMBL13683339 0.82 EPHX1 (0.42) EPHX1F2ANPEP
SCHEMBL11845878 0.82 ABAT (0.41) ABATTPSAB1HDAC3HDAC6NCOR2
SCHEMBL7041167 0.81 ENPP2 (0.46) EPHX1LOXL2NOS3NOS1NOS2
SCHEMBL22509339 0.78 EPHX1 (0.70) EPHX1ABATLOXL2NOS3NOS1
SCHEMBL3313338 0.77 EPHX1 (0.42) EPHX1F2
SCHEMBL1354759 0.76 ESR1 (0.42) KDM4E
SCHEMBL1354755 0.76 ESR1 (0.42) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885186-B1 AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM THOMAE GMBH DR K (DE) 2003-03-26 EP disclosed
US-6114390-A AN ARGININAMIDE OR ORNITHINAMIDE COMPOUND AS TREATING MEMORY LOSS, MIGRAINE, SLEEP DISORDERS, PAIN, CARDIOVASCULAR DISEASES, SUBARACHNOIDAL BLEEDING, VASCULAR-HYPERTROPHIC CHANGES, CEREBRAL AND CORONARY VASOSPASMS KARL THOMAE GMBH (DE) 2000-09-05 US disclosed
US-5962530-A NEUROPEPTIDE Y ANTAGONIST DR. KARL THOMAE GMBH (DE) 1999-10-05 US disclosed
EP-0885186-A1 AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM Dr. Karl Thomae GmbH (DE) 1998-12-23 EP disclosed
WO-1997019911-A1 AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM DR. KARL THOMAE GMBH (DE) 1997-06-05 WO disclosed